Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001384101-25-000042
Filing Date
2025-03-10
Accepted
2025-03-10 16:43:53
Documents
1
Period of Report
2025-03-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1741639425.html 4  
1 FORM 4 wk-form4_1741639425.xml 4 6963
  Complete submission text file 0001384101-25-000042.txt   8553
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O VERACYTE, INC. 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Leite John (Reporting) CIK: 0001991536 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36156 | Film No.: 25724425